|
|
| 5-Day | 13,542 |
| 10-Day | 25,818 |
| 30-Day | 26,390 |
| 5-Day | 13,542 |
| 10-Day | 25,818 |
| 30-Day | 26,390 |
| 5-Day | 326,987 |
| 10-Day | 348,374 |
| 30-Day | 407,401 |
| 5-Day | 326,987 |
| 10-Day | 348,374 |
| 30-Day | 407,401 |
Announcements
Dr Reddys Labs: FY14 results on May 13, 2014
| Days | BSE | NSE |
| 30 | 2653.17 | 2653.47 |
| 50 | 2679.59 | 2679.79 |
| 150 | 2545.78 | 2546.17 |
| 200 | 2470.23 | 2470.64 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Dec '13) | (Sep '13) |
| Net Sales | 3,533.76 | 3,357.45 |
| Other Income | 17.73 | 63.67 |
| PBDIT | 697.54 | 736.01 |
| Net Profit | 451.56 | 690.25 |
| Total Share Capital | 84.90 |
| Net Worth | 7783.40 |
| Total Debt | 1589.10 |
| Net Block | 2387.00 |
| Investments | 2379.20 |
| Net Current Assets | 4183.10 |
| Total Assets | 9372.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 626.10 | 1.09 | 653.10 | 481.50 | 129,675.57 |
| Lupin | 987.25 | 0.52 | 1012.00 | 693.70 | 44,265.90 |
| Dr Reddys Labs | 2565.45 | 0.50 | 2939.80 | 1999.40 | 43,640.58 |
| Cipla | 399.65 | 0.58 | 450.00 | 375.00 | 32,088.75 |
| GlaxoSmithKline | 2463.15 | -0.95 | 3054.40 | 2225.00 | 20,863.62 |
| More » | |||||
| Dec' 13 | Sep' 13 | Jun' 13 | Mar' 13 | |
| Promoter | 25.52 | 25.52 | 25.53 | 25.56 |
| FII | 33.35 | 32.56 | 32.69 | 29.66 |
| DII | 7.55 | 8.88 | 8.84 | 11.03 |
| Others | 33.58 | 33.04 | 32.94 | 33.75 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 760,382 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 483,456 |
| Birla Sun Life Frontline Equity Fund (G) | 386,178 |
| Franklin India Prima Plus Fund (G) | 325,488 |
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 43,640.58 crore.The company has reported a consolidated sales of Rs 3,533.76 crore and a Net Profit of Rs 451.56 crore for the quarter ended Dec 2013.
The company management includes G V Prasad - Chairman & CEO, Satish Reddy - Vice Chairman & Mng.Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Kalpana Morparia - Independent Director, Omkar Goswami - Independent Director, Ravi Bhoothalingam - Independent Director, Sridar Iyengar - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
SET SMS ALERT
